Guo et al. showed that the activation of the NF-κB pathway by expression of TLR adaptor molecules (MyD88, TRIF, or IPS-1) in hepatoma cells suppresses HBV replication and transcription29. This evidence concerns the gene MYD88 and hepatocellular carcinoma.